Skip to content

Bristol Myers Squibb Co

NYSE: BMY · USD

Bristol Myers Squibb Co cash flow and EPS58

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$2,903M
Bristol Myers Squibb Co capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2009 Q221.05% · $164MUnavailableUnavailable78.95% · $615MUnavailable100% · $779M
FY 2009 Q35.47% · $169M72.19% · $2,232MUnavailable20.25% · $626M2.1% · $65M100% · $3,092M
FY 2009 Q421.73% · $196M0% · $0MUnavailable69.4% · $626M8.87% · $80M100% · $902M
FY 2010 Q118.97% · $129MUnavailable0% · $0M81.03% · $551M0% · $0M100% · $680M
FY 2010 Q210.15% · $81MUnavailable20.68% · $165M69.17% · $552MUnavailable100% · $798M
FY 2010 Q310.76% · $89MUnavailable22.73% · $188M66.51% · $550MUnavailable100% · $827M
FY 2010 Q46.98% · $125MUnavailable12.45% · $223M30.65% · $549M49.92% · $894M100% · $1,791M
FY 2011 Q18.91% · $75MUnavailable17.58% · $148M67.1% · $565M6.41% · $54M100% · $842M
FY 2011 Q28.22% · $74MUnavailable26.33% · $237M62.78% · $565M2.67% · $24M100% · $900M
FY 2011 Q37.49% · $84MUnavailable42.25% · $474M50.27% · $564M0% · $0M100% · $1,122M
FY 2011 Q412.12% · $134M4.52% · $50M32.73% · $362M50.63% · $560M0% · $0M100% · $1,106M
FY 2012 Q13.38% · $123M68.42% · $2,491M9.31% · $339M15.9% · $579M2.99% · $109M100% · $3,641M
FY 2012 Q29.35% · $113M0% · $0M43.09% · $521M47.56% · $575M0% · $0M100% · $1,209M
FY 2012 Q31.56% · $137M57.28% · $5,039M11.95% · $1,051M6.49% · $571M22.72% · $1,999M100% · $8,797M
FY 2012 Q414.25% · $175M0% · $0M40.07% · $492M45.68% · $561M0% · $0M100% · $1,228M
FY 2013 Q111.59% · $115MUnavailable29.94% · $297M58.47% · $580MUnavailable100% · $992M
FY 2013 Q212.96% · $98MUnavailable10.98% · $83M76.06% · $575MUnavailable100% · $756M
FY 2013 Q39.18% · $124MUnavailable3.92% · $53M42.71% · $577M44.19% · $597M100% · $1,351M
FY 2013 Q425.74% · $200MUnavailable0% · $0M74.26% · $577M0% · $0M100% · $777M
FY 2014 Q18.31% · $118M1.48% · $21MUnavailable42.61% · $605M47.61% · $676M100% · $1,420M
FY 2014 Q212.22% · $110M21.33% · $192MUnavailable66.44% · $598M0% · $0M100% · $900M
FY 2014 Q315.2% · $107M0% · $0MUnavailable84.8% · $597M0% · $0M100% · $704M
FY 2014 Q424.03% · $191M0.75% · $6MUnavailable75.22% · $598M0% · $0M100% · $795M
FY 2015 Q117.92% · $136MUnavailableUnavailable82.08% · $623MUnavailable100% · $759M
FY 2015 Q221.05% · $165MUnavailableUnavailable78.95% · $619MUnavailable100% · $784M
FY 2015 Q326.35% · $234M4.17% · $37MUnavailable69.48% · $617M0% · $0M100% · $888M
FY 2015 Q425.4% · $285M19.52% · $219MUnavailable55.08% · $618M0% · $0M100% · $1,122M
FY 2016 Q121.57% · $242M0.71% · $8M20.59% · $231M57.13% · $641MUnavailable100% · $1,122M
FY 2016 Q222.6% · $261M22.42% · $259M0% · $0M54.98% · $635MUnavailable100% · $1,155M
FY 2016 Q333.4% · $341M4.31% · $44M0% · $0M62.29% · $636MUnavailable100% · $1,021M
FY 2016 Q435.2% · $371M4.55% · $48M0% · $0M60.25% · $635MUnavailable100% · $1,054M
FY 2017 Q19.52% · $291M3.66% · $112M65.4% · $2,000M21.42% · $655MUnavailable100% · $3,058M
FY 2017 Q222.59% · $248M18.85% · $207M0% · $0M58.56% · $643MUnavailable100% · $1,098M
FY 2017 Q311.78% · $262M15.87% · $353M9.89% · $220M28.76% · $640M33.71% · $750M100% · $2,225M
FY 2017 Q421.56% · $254M3.06% · $36M21.14% · $249M54.24% · $639M0% · $0M100% · $1,178M
FY 2018 Q117.13% · $239M24.09% · $336M11.97% · $167M46.81% · $653M0% · $0M100% · $1,395M
FY 2018 Q210.74% · $198M45.23% · $834M8.3% · $153M35.47% · $654M0.27% · $5M100% · $1,844M
FY 2018 Q324.3% · $224M4.88% · $45M0% · $0M70.82% · $653M0% · $0M100% · $922M
FY 2018 Q429.77% · $290M3.18% · $31M0% · $0M67.04% · $653M0% · $0M100% · $974M
FY 2019 Q19.54% · $204M0.7% · $15M0% · $0M31.29% · $669M58.47% · $1,250M100% · $2,138M
FY 2019 Q221.18% · $191M3.77% · $34M0% · $0M74.39% · $671M0.67% · $6M100% · $902M
FY 2019 Q316.24% · $190M0.77% · $9M25.64% · $300M57.35% · $671M0% · $0M100% · $1,170M
FY 2019 Q40.62% · $251M60.69% · $24,576M17.29% · $7,000M1.65% · $668M19.76% · $8,000M100% · $40,495M
FY 2020 Q114.21% · $186M1.91% · $25M6.19% · $81M77.69% · $1,017M0% · $0M100% · $1,309M
FY 2020 Q210.04% · $131M11.72% · $153M0% · $0M78.24% · $1,021M0% · $0M100% · $1,305M
FY 2020 Q35.25% · $153M8.34% · $243M0% · $0M34.89% · $1,016M51.51% · $1,500M100% · $2,912M
FY 2020 Q41.7% · $283M75.91% · $12,663M8.78% · $1,465M6.12% · $1,021M7.49% · $1,250M100% · $16,682M
FY 2021 Q12.27% · $173M0.46% · $35M23.32% · $1,775M14.55% · $1,108M59.4% · $4,522M100% · $7,613M
FY 2021 Q25.37% · $210M9.36% · $366M31.6% · $1,236M28.1% · $1,099M25.57% · $1,000M100% · $3,911M
FY 2021 Q37.84% · $270M30.71% · $1,057M15.25% · $525M31.67% · $1,090M14.53% · $500M100% · $3,442M
FY 2021 Q47.4% · $320M3.52% · $152M63.65% · $2,751M25.43% · $1,099M0% · $0M100% · $4,322M
FY 2022 Q12% · $253M3.49% · $442M39.53% · $5,000M9.37% · $1,185M45.61% · $5,769M100% · $12,649M
FY 2022 Q25.71% · $272M9.8% · $467M0% · $0M24.13% · $1,150M60.37% · $2,877M100% · $4,766M
FY 2022 Q33.03% · $247M40.02% · $3,261M8.6% · $701M14.16% · $1,154M34.18% · $2,785M100% · $8,148M
FY 2022 Q48.6% · $346M2.88% · $116M60.05% · $2,416M28.46% · $1,145M0% · $0M100% · $4,023M
FY 2023 Q18.08% · $278M2.27% · $78M7.26% · $250M34.75% · $1,196M47.65% · $1,640M100% · $3,442M
FY 2023 Q29.3% · $259M6.61% · $184M32.51% · $905M43% · $1,197M8.58% · $239M100% · $2,784M
FY 2023 Q35.84% · $342M5.56% · $326M68.27% · $4,000M20.33% · $1,191M0% · $0M100% · $5,859M
FY 2023 Q48.11% · $330M14.27% · $581M0% · $0M28.49% · $1,160M49.13% · $2,000M100% · $4,071M
FY 2024 Q11.32% · $284M93.06% · $20,053M0% · $0M5.62% · $1,212M0% · $0M100% · $21,549M
FY 2024 Q28.07% · $262M42.29% · $1,373M0% · $0M37.48% · $1,217M12.17% · $395M100% · $3,247M
FY 2024 Q37.42% · $324M7.97% · $348M0% · $0M27.85% · $1,216M56.76% · $2,478M100% · $4,366M
FY 2024 Q423.01% · $378M2.86% · $47M0% · $0M74.13% · $1,218M0% · $0M100% · $1,643M
FY 2025 Q116.29% · $260M4.89% · $78MUnavailable78.82% · $1,258M0% · $0M100% · $1,596M
FY 2025 Q214.15% · $361M11.17% · $285MUnavailable49.47% · $1,262M25.21% · $643M100% · $2,551M
FY 2025 Q38.68% · $320M50.84% · $1,874MUnavailable34.26% · $1,263M6.21% · $229M100% · $3,686M
FY 2025 Q42.76% · $370M12.73% · $1,707MUnavailable9.41% · $1,262M75.1% · $10,068M100% · $13,407M
FY 2026 Q115.81% · $347M2.96% · $65MUnavailable58.45% · $1,283M22.78% · $500M100% · $2,195M
FY 2026 Q210.51% · $305M3.13% · $91MUnavailable44.33% · $1,287M42.03% · $1,220M100% · $2,903M
Jun 30, 2009 through Jun 30, 2026

Latest period omits buybacks. Percentages cover tracked uses. SBC is noncash and excluded.

Operating cash flow

USD millions

$3,393M

Capital expenditures

USD millions

$305M

Free cash flow

USD millions

$3,088M

Stock-based compensation

USD millions

$135M

SBC / free cash flow

% · FCF before SBC deduction

4.37%

SBC / operating cash flow

%

3.98%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$1.62

Quarterly data

Bristol Myers Squibb Co cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 20263,3933053,0881354.37%3.98%—$1.62
FY 2026 Q1Mar 31, 20261,10434775714619.29%13.22%—$1.31
FY 2025 Q4Dec 31, 20251,9743701,6041338.29%6.74%——
FY 2025 Q3Sep 30, 20256,3113205,9911392.32%2.2%—$1.08
FY 2025 Q2Jun 30, 20253,9173613,5561373.85%3.5%—$0.64
FY 2025 Q1Mar 31, 20251,9542601,6941448.5%7.37%—$1.2
FY 2024 Q4Dec 31, 20244,4393784,0611202.95%2.7%——
FY 2024 Q3Sep 30, 20245,5913245,2671292.45%2.31%—$0.6
FY 2024 Q2Jun 30, 20242,3262622,0641256.06%5.37%—$0.83
FY 2024 Q1Mar 31, 20242,8342842,5501335.22%4.69%—$-5.89
FY 2023 Q4Dec 31, 20234,2523303,9221273.24%2.99%——
FY 2023 Q3Sep 30, 20234,7513424,4091322.99%2.78%—$0.93
FY 2023 Q2Jun 30, 20231,8872591,6281378.42%7.26%—$0.99
FY 2023 Q1Mar 31, 20232,9702782,6921224.53%4.11%—$1.07
FY 2022 Q4Dec 31, 20223,3063462,9601194.02%3.6%——
FY 2022 Q3Sep 30, 20223,6872473,4401153.34%3.12%—$0.75
FY 2022 Q2Jun 30, 20222,2612721,9891165.83%5.13%—$0.66
FY 2022 Q1Mar 31, 20223,8122533,5591073.01%2.81%—$0.59
FY 2021 Q4Dec 31, 20214,0573203,7371333.56%3.28%——
FY 2021 Q3Sep 30, 20215,2662704,9961422.84%2.7%—$0.69
FY 2021 Q2Jun 30, 20213,0602102,8501575.51%5.13%—$0.47
FY 2021 Q1Mar 31, 20213,8241733,6511514.14%3.95%—$0.89
FY 2020 Q4Dec 31, 20203,6702833,3871715.05%4.66%—$-4.45
FY 2020 Q3Sep 30, 20202,2191532,0661858.95%8.34%—$0.82
FY 2020 Q2Jun 30, 20204,2691314,1382135.15%4.99%—$-0.04
FY 2020 Q1Mar 31, 20203,8941863,7082105.66%5.39%—$-0.34
FY 2019 Q4Dec 31, 20192,0382511,78728415.89%13.94%—$-0.55
FY 2019 Q3Sep 30, 20192,5561902,366562.37%2.19%—$0.83
FY 2019 Q2Jun 30, 20192,0831911,892482.54%2.3%—$0.87
FY 2019 Q1Mar 31, 20191,3902041,186534.47%3.81%—$1.04
FY 2018 Q4Dec 31, 20182,4292902,139532.48%2.18%—$0.71
FY 2018 Q3Sep 30, 20181,2792241,055625.88%4.85%—$1.16
FY 2018 Q2Jun 30, 20181,057198859515.94%4.82%—$0.23
FY 2018 Q1Mar 31, 20181,175239936555.88%4.68%—$0.91
FY 2017 Q4Dec 31, 20171,117254863505.79%4.48%—$-1.42
FY 2017 Q3Sep 30, 20171,7132621,451503.45%2.92%—$0.51
FY 2017 Q2Jun 30, 20171,5842481,336544.04%3.41%—$0.56
FY 2017 Q1Mar 31, 2017861291570457.89%5.23%—$0.94
FY 2016 Q4Dec 31, 20161,4283711,057565.3%3.92%—$0.53
FY 2016 Q3Sep 30, 20161,3973411,056484.55%3.44%—$0.72
FY 2016 Q2Jun 30, 20164112611505436%13.14%—$0.69
FY 2016 Q1Mar 31, 2016-386242-62847———$0.71
FY 2015 Q4Dec 31, 20156112853265918.1%9.66%—$-0.12
FY 2015 Q3Sep 30, 20155242342906321.72%12.02%—$0.42
FY 2015 Q2Jun 30, 201571165-9459—83.1%—$-0.08
FY 2015 Q1Mar 31, 20156261364905411.02%8.63%—$0.71
FY 2014 Q4Dec 31, 20145721913816617.32%11.54%—$0.01
FY 2014 Q3Sep 30, 2014903107796486.03%5.32%—$0.43
FY 2014 Q2Jun 30, 20141,056110946505.29%4.73%—$0.2
FY 2014 Q1Mar 31, 2014617118499499.82%7.94%—$0.56
FY 2013 Q4Dec 31, 20131,4102001,210514.21%3.62%—$0.44
FY 2013 Q3Sep 30, 20131,053124929454.84%4.27%—$0.42
FY 2013 Q2Jun 30, 20131,510981,412463.26%3.05%—$0.32
FY 2013 Q1Mar 31, 2013-428115-54349———$0.37
FY 2012 Q4Dec 31, 2012836175661466.96%5.5%—$0.56
FY 2012 Q3Sep 30, 20124,5841374,447260.58%0.57%—$-0.43
FY 2012 Q2Jun 30, 20121,1341131,021403.92%3.53%—$0.38
FY 2012 Q1Mar 31, 20123871232644215.91%10.85%—$0.64
FY 2011 Q4Dec 31, 20111,5681341,434412.86%2.61%—$0.5
FY 2011 Q3Sep 30, 20111,698841,614392.42%2.3%—$0.56
FY 2011 Q2Jun 30, 20111,093741,019434.22%3.93%—$0.52
FY 2011 Q1Mar 31, 201148175406389.36%7.9%—$0.57
FY 2010 Q4Dec 31, 20101,5951251,470503.4%3.13%—$0.28
FY 2010 Q3Sep 30, 20101,383891,294473.63%3.4%—$0.55
FY 2010 Q2Jun 30, 20101,04981968495.06%4.67%—$0.53
FY 2010 Q1Mar 31, 20104641293354714.03%10.13%—$0.43
FY 2009 Q4Dec 31, 20091,3441961,148534.62%3.94%—$4.06
FY 2009 Q3Sep 30, 20091,4731691,304423.22%2.85%—$0.48
FY 2009 Q2Jun 30, 2009796164632457.12%5.65%—$0.49
Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · BMY, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.